352 related articles for article (PubMed ID: 26360919)
1. The treatment of cancer-associated venous thromboembolism in the era of the novel oral anticoagulants.
Prandoni P
Expert Opin Pharmacother; 2015; 16(16):2391-4. PubMed ID: 26360919
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.
Carrier M; Soff G; Le Gal G
Cancer Treat Res; 2019; 179():103-115. PubMed ID: 31317483
[TBL] [Abstract][Full Text] [Related]
5. Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants.
Kim SA; Yhim HY; Bang SM
J Korean Med Sci; 2019 Feb; 34(6):e52. PubMed ID: 30787683
[TBL] [Abstract][Full Text] [Related]
6. Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants.
Uppuluri EM; Burke KR; Haaf CM; Shapiro NL
J Oncol Pharm Pract; 2019 Mar; 25(2):261-268. PubMed ID: 28942721
[TBL] [Abstract][Full Text] [Related]
7. An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis.
Cosmi B
Expert Opin Pharmacother; 2021 Apr; 22(5):583-594. PubMed ID: 33243038
[No Abstract] [Full Text] [Related]
8. The role of direct oral anticoagulants in cancer-related venous thromboembolism: a perspective beyond the guidelines.
Rojas-Hernandez CM
Support Care Cancer; 2018 Mar; 26(3):711-720. PubMed ID: 29188376
[TBL] [Abstract][Full Text] [Related]
9. [Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?].
Debourdeau P; Cossou-Gbeto C; Takam-Sohwe T; Laroche JP
Bull Cancer; 2020 Feb; 107(2):224-233. PubMed ID: 32005356
[TBL] [Abstract][Full Text] [Related]
10. Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism.
Masini M; Toma M; Spallarossa P; Porto I; Ameri P
Curr Oncol Rep; 2023 Sep; 25(9):979-987. PubMed ID: 37278934
[TBL] [Abstract][Full Text] [Related]
11. LMWH in cancer patients with renal impairment - better than warfarin?
Bauersachs RM
Thromb Res; 2016 Apr; 140 Suppl 1():S160-4. PubMed ID: 27067971
[TBL] [Abstract][Full Text] [Related]
12. An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism.
Martins MA; Silva TF; Fernandes CJ
Curr Oncol Rep; 2023 May; 25(5):425-432. PubMed ID: 36928825
[TBL] [Abstract][Full Text] [Related]
13. Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society.
Milani A; Tuninetti V; Pignata S; Lorusso D; Castaldo D; De Giorgi U; Savarese A; Biglia N; Scandurra G; Mangili G; Di Maio M; Turinetto M; Bellero M; Mammoliti S; Testa S; Scotto G; Purro A; Artioli G; Valabrega G
Tumori; 2023 Oct; 109(5):490-495. PubMed ID: 36609207
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline.
Riess H; Beyer-Westendorf J; Pelzer U; Klamroth R; Linnemann B
Hamostaseologie; 2024 Apr; 44(2):143-149. PubMed ID: 37992730
[TBL] [Abstract][Full Text] [Related]
15. The Treatment of Venous Thromboembolism in Patients with Cancer.
Prandoni P
Adv Exp Med Biol; 2017; 906():123-135. PubMed ID: 27620308
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Review of Prescribing Patterns in Cancer-Associated Thrombosis: A Single Center Experience in Edmonton, Alberta, Canada.
Kaliel H; Mior M; Quan S; Ghosh S; Wu C; Bungard TJ
Clin Appl Thromb Hemost; 2021; 27():1076029620975489. PubMed ID: 33443455
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives.
Overvad TF; Larsen TB; Søgaard M; Albertsen IE; Ording AG; Noble S; Højen AA; Nielsen PB
Expert Rev Cardiovasc Ther; 2020 Nov; 18(11):791-800. PubMed ID: 32909840
[TBL] [Abstract][Full Text] [Related]
18. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Khorana AA; Yannicelli D; McCrae KR; Milentijevic D; Crivera C; Nelson WW; Schein JR
Thromb Res; 2016 Sep; 145():51-3. PubMed ID: 27485998
[TBL] [Abstract][Full Text] [Related]
20. What are the pharmacotherapy options for treating venous thromboembolism in cancer patients?
Prandoni P; Piovella C; Filippi L; Vedovetto V; Dalla Valle F; Piccioli A
Expert Opin Pharmacother; 2014 Apr; 15(6):799-807. PubMed ID: 24548179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
